ReShape Lifesciences Inc. executed a 1-for-25 reverse stock split on May 6, 2025, approved by shareholders on April 1, 2025, effective for trading on May 9, 2025, which will result in each 25 shares being converted into one share. This action does not change the total number of authorized shares but increases the available number of shares for issuance.